Cim Investment Management Inc Xencor Inc Transaction History

Cim Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$26.68 - $41.63 $147,860 - $230,713	-5,542 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$33.67 - $43.44 $186,599 - $240,744	5,542 New	5,542 $222,000
Q2 2021 Aug 13, 2021	SELL	$34.33 - $44.68 $190,256 - $247,616	-5,542 Closed	0 $0
Q1 2021 May 20, 2021	SELL	$40.81 - $53.88 $13,467 - $17,780	-330 Reduced 5.62%	5,542 $239,000
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $176,688 - $252,613	5,872 New	5,872 $228,000

216

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.